Patent - Abbreviated New Drug Application Cases filed in Delaware
Cases 21 - 30 of 33
In re: Sitagliptin Phosphate ('708 & '921) Patent Litigation
as 1:2019md02902
Counter Defendant: Merck Sharp & Dohme Corp.
Not Classified By Court: Teva Pharmaceuticals USA, Inc., Torrent Pharma Inc., Torrent Pharmaceuticals Limited and others
Counter Claimant: Macleods Pharmaceuticals Limited
In Re: In re: Sitagliptin Phosphate ('708 & '921) Patent Litigation
Defendant: Accord Healthcare, Inc., Teva Pharmaceutical Industries Ltd., Inventia Healthcare Ltd. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Genentech, Inc. et al v. Sandoz, Inc. et al
as 1:2019cv00203
Plaintiff: Genentech, Inc. and InterMune, Inc.
Defendant: Sandoz AG, Sandoz International GmbH and Sandoz, Inc.
Cause Of Action: 35 U.S.C. § 271
Genentech, Inc. et al v. Sandoz, Inc. et al
as 1:2019cv00202
Plaintiff: Genentech, Inc. and InterMune, Inc.
Defendant: Sandoz AG, Sandoz International GmbH and Sandoz, Inc.
Cause Of Action: 35 U.S.C. § 271
Astellas US LLC et al v. Sandoz Inc.
as 1:2018cv01676
Defendant: Sandoz Inc.
Plaintiff: Gilead Sciences, Inc., Astellas US LLC and Astellas Pharma US, Inc.
Cause Of Action: 35 U.S.C. § 271
Pharmacyclics LLC et al v. Zydus Worldwide DMCC et al
as 1:2018cv00275
Defendant: Teva Pharmaceuticals USA, Inc., Zydus Worldwide DMCC, Lek Pharmaceuticals d.d. and others
Plaintiff: Pharmacyclics LLC and Janssen Biotech, Inc.
Cause Of Action: 35 U.S.C. § 271
Pharmacyclics LLC et al v. Sandoz Inc. et al We have downloadable decisions or orders for this case
as 1:2018cv00192
Defendant: Fresenius Kabi Oncology Limited, Fresenius Kabi USA, Inc., Fresenius Kabi USA, LLC and others
Plaintiff: Pharmacyclics LLC and Janssen Biotech Inc.
Counter Claimant: Cipla USA Inc., Lek Pharmaceuticals d.d., Cadila Healthcare Limited and others
Cause Of Action: 35 U.S.C. § 271
H. Lundbeck A/S et al v. Sandoz Inc. et al
as 1:2018cv00177
Plaintiff: H. Lundbeck A/S , Takeda Pharmaceutical Company Ltd. , Takeda Pharmaceuticals U.S.A., Inc. and others
Defendant: Sandoz Inc., Sandoz AG and Lek Pharmaceuticals d.d.
Cause Of Action: 35 U.S.C. § 271
Forest Laboratories Holdings, Ltd. et al v. Sandoz Inc.
as 1:2018cv00171
Plaintiff: Forest Laboratories Holdings, Ltd. , Allergan USA, Inc. , Allergan Sales, LLC and others
Defendant: Sandoz Inc.
Cause Of Action: 35 U.S.C. § 271
H. Lundbeck A/S et al v. Lupin Limited, et al We have downloadable decisions or orders for this case
as 1:2018cv00088
Counter Defendant: Takeda Pharmaceutical Company Ltd.
Plaintiff: Takeda Pharmaceuticals International AG, H. Lundbeck A/S, Takeda Pharmaceuticals U.S.A., Inc. and others
Defendant: Apotex Inc., Apotex Research Private Limited, Apotex Corp. and others
Counter Claimant: Unichem Laboratories, Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
ViiV Healthcare Company et al v. Sandoz Inc. et al
as 1:2017cv01784
Plaintiff: ViiV Healthcare Company , Shionogi & Co., Ltd. and ViiV Healthcare UK (No. 3) Limited
Defendant: Sandoz Inc. , Sandoz AG and Lek Pharmaceuticals d.d.
Cause Of Action: 35 U.S.C. § 271

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?